LINCOLN PHARMA LTD (LINCOLN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1979, Lincoln Pharmaceuticals Ltd is in the business of manufacturing and trading of pharmaceutical products[1]

LINCOLNUpdated 2 Sept 2026, 3:48

Lincoln Pharma Ltd

Market Cap

₹1,221Cr.

Current Price

₹610

High / Low

₹770/440

Stock P/E

12.7

ROE12.3%
ROCE16.3%
Book Value₹378
Face Value₹10.0
Dividend Yield0.30%

About

Incorporated in 1979, Lincoln Pharmaceuticals Ltd is in the business of manufacturing and trading of pharmaceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1358895108117889789971019787
Inventory Days494467786173861211061019994
Days Payable343753757482105119779510699
Cash Conversion Cycle150961101111048078911261088982
Working Capital Days8350749096111120114121121116239
ROCE %16%20%19%18%22%22%25%24%22%22%17%16%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 2 September 2026 at 3:48


Designed & Shipped by Harshit Bansal